Therapeutic effects of green tea on endometriosis

References

• Abbott, J., J. Hawe, D. Hunter, M. Holmes, P. Finn, and R. Garry. 2004. Laparoscopic excision of endometriosis: A randomized, placebo-controlled trial. Fertility and Sterility 82 (4):878–84.
   PubMed Web of Science ®Google Scholar
• Ahmad, N., S. Gupta, and H. Mukhtar. 2000. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Archives of Biochemistry and Biophysics 376 (2):338–46.
   PubMed Web of Science ®Google Scholar
• Annabi, B., M. P. Lachambre, N. Bousquet-Gagnon, M. Page, D. Gingras, and R. Beliveau. 2002. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochimica et Biophysica Acta 1542 (1-3):209–20.
   PubMed Web of Science ®Google Scholar
• Bartosik, D., S. L. Jacobs, and L. J. Kelly. 1986. Endometrial tissue in peritoneal fluid. Fertility and Sterility 46 (5):796–800.
   PubMed Web of Science ®Google Scholar
• Beltz, L. A., D. K. Bayer, A. L. Moss, and I. M. Simet. 2006. Mechanisms of cancer prevention by green and black tea polyphenols. Anti-Cancer Agents in Medicinal Chemistry 6 (5):389–406.
   PubMedGoogle Scholar
• Belza, A., S. Toubro, and A. Astrup. 2009. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. European Journal of Clinical Nutrition 63 (1):57–64. doi: 10.1038/sj.ejcn.1602901.
   PubMed Web of Science ®Google Scholar
• Berbic, M., L. Schulke, R. Markham, N. Tokushige, P. Russell, and I. S. Fraser. 2009. Macrophage expression in endometrium of women with and without endometriosis. Human Reproduction 24 (2):325–32. doi: 10.1093/humrep/den393.
   PubMed Web of Science ®Google Scholar
• Bhatti, S. K., J. H. O’keefe, and C. J. Lavie. 2013. Coffee and tea: Perks for health and longevity? Current Opinion in Clinical Nutrition and Metabolic Care 16 (6):688–97.
   PubMed Web of Science ®Google Scholar
• Braun, D. P., A. Muriana, H. Gebel, C. Rotman, N. Rana, and W. P. Dmowski. 1994. Monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis. Fertility and Sterility 61 (1):78–84.
   PubMed Web of Science ®Google Scholar
• Brosens, I., P. Koninckx, and W. Boeckx. 1981. Endometriosis. Clinics in Obstetrics and Gynaecology 8 (3):639–51.
   PubMedGoogle Scholar
• Brusselmans, K., E. De Schrijver, W. Heyns, G. Verhoeven, and J. V. Swinnen. 2003. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. International Journal of Cancer 106 (6):856–62. doi: 10.1002/ijc.11317.
   PubMed Web of Science ®Google Scholar
• Budinetz, T., and J. S. Sanfilippo. 2010. Treatment of endometriosis: A hormonal approach. Minerva Ginecologica 62 (4):373–80.
   PubMedGoogle Scholar
• Burney, R. O., and L. C. Giudice. 2012. Pathogenesis and pathophysiology of endometriosis. Fertility and Sterility 98 (3):511–9. doi: 10.1016/j.fertnstert.2012.06.029.
   PubMed Web of Science ®Google Scholar
• Butt, M. S., R. S. Ahmad, M. T. Sultan, M. M. Qayyum, and A. Naz. 2015. Green tea and anticancer perspectives: Updates from last decade. Critical Reviews in Food Science and Nutrition 55 (6):792–805.
   PubMed Web of Science ®Google Scholar
• Chacko, S. M., P. T. Thambi, R. Kuttan, and I. Nishigaki. 2010. Beneficial effects of green tea: A literature review. Chinese Medicine 5:13.
   PubMedGoogle Scholar
• Chen, F. Y., X. Wang, R. Y. Tang, Z. X. Guo, Y. Z. Deng, and Q. Yu. 2019. New therapeutic approaches for endometriosis besides hormonal therapy. Chinese Medical Journal 132 (24):2984–93.
   PubMed Web of Science ®Google Scholar
• Chen, D., S. B. Wan, H. Yang, J. Yuan, T. H. Chan, and Q. P. Dou. 2011. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Advances in Clinical Chemistry 53:155–77.
   PubMed Web of Science ®Google Scholar
• Chow, H. H., Y. Cai, I. A. Hakim, J. A. Crowell, F. Shahi, C. A. Brooks, R. T. Dorr, Y. Hara, and D. S. Alberts. 2003. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9 (9):3312–9.
   PubMed Web of Science ®Google Scholar
• Chow, H. H., I. A. Hakim, D. R. Vining, J. A. Crowell, J. Ranger-Moore, W. M. Chew, C. A. Celaya, S. R. Rodney, Y. Hara, and D. S. Alberts. 2005. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11 (12):4627–33. doi: 10.1158/1078-0432.CCR-04-2549.
   PubMed Web of Science ®Google Scholar
• Chung, F. L., J. Schwartz, C. R. Herzog, and Y. M. Yang. 2003. Tea and cancer prevention: Studies in animals and humans. The Journal of Nutrition 133 (10):3268S–74S. doi: 10.1093/jn/133.10.3268S.
   PubMed Web of Science ®Google Scholar
• Costa, L. M., S. T. Gouveia, and J. A. Nobrega. 2002. Comparison of heating extraction procedures for Al, Ca, Mg, and Mn in tea samples. Analytical Sciences: The International Journal of the Japan Society for Analytical Chemistry 18 (3):313–8.
   PubMed Web of Science ®Google Scholar
• Cramer, D. W., and S. A. Missmer. 2002. The epidemiology of endometriosis. Annals of the New York Academy of Sciences 955:11–22. discussion 34-6, 396-406. doi: 10.1111/j.1749-6632.2002.tb02761.x.
   PubMed Web of Science ®Google Scholar
• Darling, A. M., J. E. Chavarro, S. Malspeis, H. R. Harris, and S. A. Missmer. 2013. A prospective cohort study of Vitamins B, C, E, and multivitamin intake and endometriosis. Journal of Endometriosis 5:17–26.
   PubMedGoogle Scholar
• Dictor, M., C. E. Nelson, and B. Uvelius. 1988. Priapism in a patient with endometrioid prostatic carcinoma. A case report. Urologia Internationalis 43 (4):245–7. doi: 10.1159/000281347.
   PubMed Web of Science ®Google Scholar
• Diepvens, K., E. M. Kovacs, I. M. Nijs, N. Vogels, and M. S. Westerterp-Plantenga. 2005. Effect of green tea on resting energy expenditure and substrate oxidation during weight loss in overweight females. British Journal of Nutrition 94 (6):1026–34. doi: 10.1079/BJN20051580.
   PubMed Web of Science ®Google Scholar
• Ding, S., S. Xu, J. Fang, and H. Jiang. 2020. The protective effect of polyphenols for colorectal cancer. Frontiers in Immunology 11:1407.
   PubMed Web of Science ®Google Scholar
• Donnez, J., P. Smoes, S. Gillerot, F. Casanas-Roux, and M. Nisolle. 1998. Vascular endothelial growth factor (VEGF) in endometriosis. Human Reproduction (Oxford, England) 13 (6):1686–90. doi: 10.1093/humrep/13.6.1686.
   PubMed Web of Science ®Google Scholar
• Donnez, J., A. Van Langendonckt, F. Casanas-Roux, J. P. Van Gossum, C. Pirard, P. Jadoul, J. Squifflet, and M. Smets. 2002. Current thinking on the pathogenesis of endometriosis. Gynecologic and Obstetric Investigation, 54(Suppl 1), 52–8. discussion 59–62.
   PubMedGoogle Scholar
• Efstathiou, J., D. Sampson, Z. Levine, R. Rohan, D. Zurakowski, J. Folkman, R. Damato, and M. Rupnick. 2005. Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model. Fertility and Sterility 83 (1):171–81. doi: 10.1016/j.fertnstert.2004.06.058.
   PubMed Web of Science ®Google Scholar
• Fan, F. S. 2016. Iron deficiency anemia due to excessive green tea drinking. Clinical Case Reports 4 (11):1053–6.
   PubMed Web of Science ®Google Scholar
• Fassina, G., R. Vene, M. Morini, S. Minghelli, R. Benelli, D. M. Noonan, and A. Albini. 2004. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10 (14):4865–73.
   PubMed Web of Science ®Google Scholar
• Felson, H., G. J. Mc, and P. Wasserman. 1960. Stromal endometriosis involving the heart. The American Journal of Medicine 29:1072–6.
   PubMed Web of Science ®Google Scholar
• Garbisa, S., L. Sartor, S. Biggin, B. Salvato, R. Benelli, and A. Albini. 2001. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91 (4):822–32. doi: 10.1002/1097-0142(20010215)91:4<822::AID-CNCR1070>3.0.CO;2-G.
   PubMed Web of Science ®Google Scholar
• Guan, Q. H., W. J. Shi, L. S. Zhou, A. L. Tao, and L. Li. 2020. Effect of epigallocatechin-3-gallate on the status of DNA methylation of E-cadherin promoter region on endometriosis mouse. The Journal of Obstetrics and Gynaecology Research 46 (10):2076–83.
   PubMedGoogle Scholar
• Guo, Q., B. Zhao, M. Li, S. Shen, and W. Xin. 1996. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochimica et Biophysica Acta 1304 (3):210–22.
   PubMedGoogle Scholar
• Hamdaoui, M. H., S. Chabchoub, and A. Hedhili. 2003. Iron bioavailability and weight gains to iron-deficient rats fed a commonly consumed Tunisian meal ‘bean seeds ragout’ with or without beef and with green or black tea decoction. Journal of Trace Elements in Medicine and Biology 17 (3):159–64. doi: 10.1016/S0946-672X(03)80020-2.
   PubMed Web of Science ®Google Scholar
• Hasegawa, R., T. Chujo, K. Sai-Kato, T. Umemura, A. Tanimura, and Y. Kurokawa. 1995. Preventive effects of green tea against liver oxidative DNA damage and hepatotoxicity in rats treated with 2-nitropropane. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 33 (11):961–70.
   PubMed Web of Science ®Google Scholar
• Hastak, K., S. Gupta, N. Ahmad, M. K. Agarwal, M. L. Agarwal, and H. Mukhtar. 2003. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 22 (31):4851–9.
   PubMed Web of Science ®Google Scholar
• Henning, S. M., Y. Niu, Y. Liu, N. H. Lee, Y. Hara, G. D. Thames, R. R. Minutti, C. L. Carpenter, H. Wang, and D. Heber. 2005. Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. The Journal of Nutritional Biochemistry 16 (10):610–6. doi: 10.1016/j.jnutbio.2005.03.003.
   PubMed Web of Science ®Google Scholar
• Herington, J. L., K. L. Bruner-Tran, J. A. Lucas, and K. G. Osteen. 2011. Immune interactions in endometriosis. Expert Review of Clinical Immunology 7 (5):611–26.
   PubMed Web of Science ®Google Scholar
• Huang, Y. J., K. L. Wang, H. Y. Chen, Y. F. Chiang, and S. M. Hsia. 2020. Protective effects of epigallocatechin gallate (EGCG) on endometrial, breast, and ovarian cancers. Biomolecules 10 (11):1481. doi: 10.3390/biom10111481.
   PubMed Web of Science ®Google Scholar
• Hudson, Q. J., K. Ashjaei, A. Perricos, L. Kuessel, H. Husslein, R. Wenzl, and I. Yotova. 2020. Endometriosis patients show an increased M2 response in the peritoneal CD14(+low)/CD68(+low) macrophage subpopulation coupled with an increase in the T-helper 2 and T-regulatory cells. Reproductive Sciences (Thousand Oaks, CA) 27 (10):1920–31.
   PubMed Web of Science ®Google Scholar
• Hurrell, R. F., M. Reddy, and J. D. Cook. 1999. Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. British Journal of Nutrition 81 (4):289–95. doi: 10.1017/S0007114599000537.
   PubMed Web of Science ®Google Scholar
• Inagake, M., T. Yamane, Y. Kitao, K. Oya, H. Matsumoto, N. Kikuoka, H. Nakatani, T. Takahashi, H. Nishimura, and A. Iwashima. 1995. Inhibition of 1,2-dimethylhydrazine-induced oxidative DNA damage by green tea extract in rat. Japanese Journal of Cancer Research: Gann 86 (11):1106–11.
   PubMedGoogle Scholar
• Jatoi, A., N. Ellison, P. A. Burch, J. A. Sloan, S. R. Dakhil, P. Novotny, W. Tan, T. R. Fitch, K. M. Rowland, C. Y. Young, et al. 2003. A phase II trial of green tea in the treatment of patients with ­androgen independent metastatic prostate carcinoma. Cancer 97 (6):1442–6.
   PubMed Web of Science ®Google Scholar
• Jenkins, S., D. L. Olive, and A. F. Haney. 1986. Endometriosis: Pathogenetic implications of the anatomic distribution. Obstetrics and Gynecology 67 (3):335–8.
   PubMed Web of Science ®Google Scholar
• Jung, Y. D., M. S. Kim, B. A. Shin, K. O. Chay, B. W. Ahn, W. Liu, C. D. Bucana, G. E. Gallick, and L. M. Ellis. 2001. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. British Journal of Cancer 84 (6):844–50. doi: 10.1054/bjoc.2000.1691.
   PubMed Web of Science ®Google Scholar
• Kabbinavar, F., H. I. Hurwitz, L. Fehrenbacher, N. J. Meropol, W. F. Novotny, G. Lieberman, S. Griffing, and E. Bergsland. 2003. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21 (1):60–5. doi: 10.1200/JCO.2003.10.066.
   PubMed Web of Science ®Google Scholar
• Katiyar, S. K., M. S. Matsui, C. A. Elmets, and H. Mukhtar. 1999. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochemistry and Photobiology 69 (2):148–53. doi: 10.1562/0031-8655(1999)069<0148:PAEGFG>2.3.CO;2.
   PubMed Web of Science ®Google Scholar
• Kennedy, S., A. Bergqvist, C. Chapron, T. D’hooghe, G. Dunselman, R. Greb, L. Hummelshoj, A. Prentice, and E. Saridogan, Endometriosis, E. S. I. G. F. & Endometrium Guideline Development, G. 2005. ESHRE guideline for the diagnosis and treatment of endometriosis. Human Reproduction (Oxford, England) 20 (10):2698–704.
   PubMed Web of Science ®Google Scholar
• Khan, N., and H. Mukhtar. 2007. Tea polyphenols for health promotion. Life Sciences 81 (7):519–33. doi: 10.1016/j.lfs.2007.06.011.
   PubMed Web of Science ®Google Scholar
• Kistner, R. W. 1959. Conservative management of endometriosis. The Journal-Lancet 79 (5):179–83.
   PubMedGoogle Scholar
• Kojima-Yuasa, A., J. J. Hua, D. O. Kennedy, and I. Matsui-Yuasa. 2003. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Life Sciences 73 (10):1299–313.
   PubMed Web of Science ®Google Scholar
• Kondo, T., T. Ohta, K. Igura, Y. Hara, and K. Kaji. 2002. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Letters 180 (2):139–44. doi: 10.1016/S0304-3835(02)00007-1.
   PubMed Web of Science ®Google Scholar
• Koninckx, P. R., S. H. Kennedy, and D. H. Barlow. 1999. Pathogenesis of endometriosis: The role of peritoneal fluid. Gynecologic and Obstetric Investigation 47 Suppl 1:23–33.
   PubMed Web of Science ®Google Scholar
• Lakka, S. S., C. S. Gondi, and J. S. Rao. 2005. Proteases and glioma angiogenesis. Brain Pathology (Zurich, Switzerland) 15 (4):327–41. doi: 10.1111/j.1750-3639.2005.tb00118.x.
   PubMed Web of Science ®Google Scholar
• Lam, W. H., A. Kazi, D. J. Kuhn, L. M. Chow, A. S. Chan, Q. P. Dou, and T. H. Chan. 2004. A potential prodrug for a green tea polyphenol proteasome inhibitor: Evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]. Bioorganic and Medicinal Chemistry 12 (21):5587–93. doi: 10.1016/j.bmc.2004.08.002.
   PubMed Web of Science ®Google Scholar
• Laschke, M. W., C. Schwender, C. Scheuer, B. Vollmar, and M. D. Menger. 2008. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Human Reproduction 23 (10):2308–18. doi: 10.1093/humrep/den245.
   PubMed Web of Science ®Google Scholar
• Lazrak, M., K. El Kari, N. U. Stoffel, L. Elammari, A. Al-Jawaldeh, C. U. Loechl, A. Yahyane, A. Barkat, M. B. Zimmermann, and H. Aguenaou. 2021. Tea consumption reduces iron bioavailability from NaFeEDTA in nonanemic women and women with iron deficiency anemia: Stable iron isotope studies in Morocco. The Journal of Nutrition 151 (9):2714–20. doi: 10.1093/jn/nxab159.
   PubMed Web of Science ®Google Scholar
• Levites, Y., M. B. Youdim, G. Maor, and S. Mandel. 2002. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochemical Pharmacology 63 (1):21–9.
   PubMed Web of Science ®Google Scholar
• Luo, H. Q., M. Xu, W. T. Zhong, Z. Y. Cui, F. M. Liu, K. Y. Zhou, and X. Y. Li. 2014. EGCG decreases the expression of HIF-1alpha and VEGF and cell growth in MCF-7 breast cancer cells. Journal of Buon 19:435–9.
   PubMed Web of Science ®Google Scholar
• Maeda-Yamamoto, M., H. Kawahara, N. Tahara, K. Tsuji, Y. Hara, and M. Isemura. 1999. Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells. Journal of Agricultural and Food Chemistry 47 (6):2350–4.
   PubMed Web of Science ®Google Scholar
• Mahutte, N. G., and A. Arici. 2003. Medical management of endometriosis-associated pain. Obstetrics and Gynecology Clinics of North America 30 (1):133–50.
   PubMed Web of Science ®Google Scholar
• Man, G. C. W., J. Wang, Y. Song, J. H. Wong, Y. Zhao, T. S. Lau, K. T. Leung, T. H. Chan, H. Wang, J. Kwong, et al. 2020. Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer. BMC Cancer 20 (1):964.
   PubMed Web of Science ®Google Scholar
• Matsuzaki, S., and C. Darcha. 2014. Antifibrotic properties of epigallocatechin-3-gallate in endometriosis. Human Reproduction (Oxford, England) 29 (8):1677–87.
   PubMed Web of Science ®Google Scholar
• Mclaren, J., A. Prentice, D. S. Charnock-Jones, and S. K. Smith. 1996. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Human Reproduction (Oxford, England) 11 (1):220–3.
   PubMed Web of Science ®Google Scholar
• Min, K. J., and T. K. Kwon. 2014. Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate. Integrative Medicine Research 3 (1):16–24.
   PubMedGoogle Scholar
• Mitchell, A. O., A. P. Hoffman, S. E. Swartz, and B. C. Ghosh. 1991. An unusual occurrence of endometriosis in the right groin: A case report and review of the literature. Military Medicine 156 (11):633–4.
   PubMed Web of Science ®Google Scholar
• Miura, Y., T. Chiba, S. Miura, I. Tomita, K. Umegaki, M. Ikeda, and T. Tomita. 2000. Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: An ex vivo study in humans. Journal of Nutritional Biochemistry 11 (4):216–22. doi: 10.1016/S0955-2863(00)00068-1.
   PubMed Web of Science ®Google Scholar
• Nagle, D. G., D. Ferreira, and Y. D. Zhou. 2006. Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry 67 (17):1849–55.
   PubMed Web of Science ®Google Scholar
• Nakagawa, K., M. Ninomiya, T. Okubo, N. Aoi, L. R. Juneja, M. Kim, K. Yamanaka, and T. Miyazawa. 1999. Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans. Journal of Agricultural and Food Chemistry 47 (10):3967–73.
   PubMed Web of Science ®Google Scholar
• Nam, S., D. M. Smith, and Q. P. Dou. 2001. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. The Journal of Biological Chemistry 276 (16):13322–30.
   PubMed Web of Science ®Google Scholar
• Negishi, H., J. W. Xu, K. Ikeda, M. Njelekela, Y. Nara, and Y. Yamori. 2004. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. The Journal of Nutrition 134 (1):38–42.
   PubMed Web of Science ®Google Scholar
• Niu, Y. J., Z. Y. Shen, C. Xu, C. F. Li, X. J. Liu, Y. Q. Teng, H. Chen, L. Li, H. M. Cheng, X. M. Yang, et al. 2013. Establishment of tacrolimus-induced diabetes in rat model and assessment of clinical treatments for post-transplant diabetes mellitus in liver transplant recipients. Clinical Laboratory 59:869–74.
   PubMed Web of Science ®Google Scholar
• Ohishi, T., S. Goto, P. Monira, M. Isemura, and Y. Nakamura. 2016. Anti-inflammatory action of green tea. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 15 (2):74–90.
   PubMedGoogle Scholar
• Olive, D. L., and E. A. Pritts. 2001. Treatment of endometriosis. The New England Journal of Medicine 345 (4):266–75.
   PubMed Web of Science ®Google Scholar
• Parasar, P., P. Ozcan, and K. L. Terry. 2017. Endometriosis: Epidemiology, diagnosis and clinical management. Current Obstetrics and Gynecology Reports 6 (1):34–41.
   PubMed Web of Science ®Google Scholar
• Park, J. S., M. H. Kim, H. J. Chang, K. M. Kim, S. M. Kim, B. A. Shin, B. W. Ahn, and Y. D. Jung. 2006. Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2. International Journal of Oncology 29 (5):1247–52. doi: 10.3892/ijo.29.5.1247.
   PubMed Web of Science ®Google Scholar
• Patel, B. G., E. E. Lenk, D. I. Lebovic, Y. Shu, J. Yu, and R. N. Taylor. 2018. Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways. Best Practice & Research. Clinical Obstetrics & Gynaecology 50:50–60.
   PubMed Web of Science ®Google Scholar
• Pollack, R., P. H. Gordon, A. Ferenczy, and T. Tulandi. 1990. Perineal endometriosis. A case report. The Journal of Reproductive Medicine 35 (2):109–12.
   PubMed Web of Science ®Google Scholar
• Ricci, A. G., C. N. Olivares, M. A. Bilotas, J. I. Baston, J. J. Singla, G. F. Meresman, and R. I. Baranao. 2013. Natural therapies assessment for the treatment of endometriosis. Human Reproduction 28 (1):178–88. doi: 10.1093/humrep/des369.
   PubMed Web of Science ®Google Scholar
• Risau, W. 1997. Mechanisms of angiogenesis. Nature 386 (6626):671–4. doi: 10.1038/386671a0.
   PubMed Web of Science ®Google Scholar
• Rudelle, S., M. G. Ferruzzi, I. Cristiani, J. Moulin, K. Mace, K. J. Acheson, and L. Tappy. 2007. Effect of a thermogenic beverage on 24-hour energy metabolism in humans. Obesity (Silver Spring) 15 (2):349–55. doi: 10.1038/oby.2007.529.
   PubMed Web of Science ®Google Scholar
• Ryan, P., and M. J. Hynes. 2007. The kinetics and mechanisms of the complex formation and antioxidant behaviour of the polyphenols EGCg and ECG with iron(III). Journal of Inorganic Biochemistry 101 (4):585–93.
   PubMed Web of Science ®Google Scholar
• Sampson, J. A. 1927. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. The American Journal of Pathology 3 (2):93–110 43.
   PubMedGoogle Scholar
• Schoonbroodt, S., and J. Piette. 2000. Oxidative stress interference with the nuclear factor-kappa B activation pathways. Biochemical Pharmacology 60 (8):1075–83.
   PubMed Web of Science ®Google Scholar
• Schweppe, K. W. 2001. Current place of progestins in the treatment of endometriosis-related complaints. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology 15(Suppl 6):22–8.
   PubMedGoogle Scholar
• Schweppe, K. W. 2005. Endometriosis market research: An overview of findings in Europe and the United States. Drugs of Today (Barcelona, Spain: 1998) 41(Suppl A):1–4.
   PubMedGoogle Scholar
• Seifert, J. G., A. Nelson, J. Devonish, E. R. Burke, and S. J. Stohs. 2011. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans. International Journal of Medical Sciences 8 (3):192–7.
   PubMed Web of Science ®Google Scholar
• Shankar, S., S. Ganapathy, S. R. Hingorani, and R. K. Srivastava. 2008. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Frontiers in Bioscience: A Journal and Virtual Library 13:440–52.
   PubMed Web of Science ®Google Scholar
• Sharifi-Rad, M., R. Pezzani, M. Redaelli, M. Zorzan, M. Imran, A. Ahmed Khalil, B. Salehi, F. Sharopov, W. C. Cho, and J. Sharifi-Rad. 2020. Preclinical pharmacological activities of epigallocatechin-3-gallate in signaling pathways: an update on cancer. Molecules 25 (3):467.
   PubMed Web of Science ®Google Scholar
• Shen, C. L., and M. C. Chyu. 2016. Tea flavonoids for bone health: From animals to humans. Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research 64 (7):1151–7.
   PubMed Web of Science ®Google Scholar
• Shifren, J. L., J. F. Tseng, C. J. Zaloudek, I. P. Ryan, Y. G. Meng, N. Ferrara, R. B. Jaffe, and R. N. Taylor. 1996. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. The Journal of Clinical Endocrinology and Metabolism 81 (8):3112–8.
   PubMed Web of Science ®Google Scholar
• Singh, B. N., S. Shankar, and R. K. Srivastava. 2011. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemical Pharmacology 82 (12):1807–21.
   PubMed Web of Science ®Google Scholar
• Slivova, V., G. Zaloga, S. J. Demichele, P. Mukerji, Y. S. Huang, R. Siddiqui, K. Harvey, T. Valachovicova, and D. Sliva. 2005. Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells. Nutrition and Cancer 52 (1):66–73.
   PubMed Web of Science ®Google Scholar
• Spinella, F., L. Rosano, V. Di Castro, S. Decandia, A. Albini, M. R. Nicotra, P. G. Natali, and A. Bagnato. 2006. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Molecular Cancer Therapeutics 5 (6):1483–92.
   PubMed Web of Science ®Google Scholar
• Spiteller, G. 2001. Lipid peroxidation in aging and age-dependent diseases. Experimental Gerontology 36 (9):1425–57.
   PubMed Web of Science ®Google Scholar
• Strasly, M., F. Cavallo, M. Geuna, S. Mitola, M. P. Colombo, G. Forni, and F. Bussolino. 2001. IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. Journal of Immunology (Baltimore, MD: 1950) 166 (6):3890–9.
   PubMed Web of Science ®Google Scholar
• Surrey, E. S., and M. D. Hornstein. 2002. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: Long-term follow-up. Obstetrics & Gynecology 99:709–19.
   PubMed Web of Science ®Google Scholar
• Sutton, C. J. 1991. What can we expect from the surgical management of endometriosis? British Journal of Clinical Practice. Supplement 72:33–42. discussion 43-4.
   PubMedGoogle Scholar
• Sutton, C. J., A. S. Pooley, S. P. Ewen, and P. Haines. 1997. Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis. Fertility and Sterility 68 (6):1070–4. doi: 10.1016/S0015-0282(97)00403-2.
   PubMed Web of Science ®Google Scholar
• Tang, F. Y., and M. Meydani. 2001. Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production. Nutrition and Cancer 41 (1–2):119–25.
   PubMed Web of Science ®Google Scholar
• Tariverdian, N., T. C. Theoharides, F. Siedentopf, G. Gutierrez, U. Jeschke, G. A. Rabinovich, S. M. Blois, and P. C. Arck. 2007. Neuroendocrine-immune disequilibrium and endometriosis: An interdisciplinary approach. Seminars in Immunopathology 29 (2):193–210.
   PubMed Web of Science ®Google Scholar
• Thephinlap, C., S. Ounjaijean, U. Khansuwan, S. Fucharoen, J. B. Porter, and S. Srichairatanakool. 2007. Epigallocatechin-3-gallate and epicatechin-3-gallate from green tea decrease plasma non-transferrin bound iron and erythrocyte oxidative stress. Medicinal Chemistry (Shariqah (United Arab Emirates)) 3 (3):289–96. doi: 10.2174/157340607780620608.
   PubMed Web of Science ®Google Scholar
• Thibodeau, L. L., G. R. Prioleau, E. E. Manuelidis, M. J. Merino, and M. D. Heafner. 1987. Cerebral endometriosis. Case report. Journal of Neurosurgery 66 (4):609–10.
   PubMed Web of Science ®Google Scholar
• Thiruchelvam, U., M. Wingfield, and C. O’farrelly. 2015. Natural Killer Cells: Key Players in Endometriosis. American Journal of Reproductive Immunology (New York, NY: 1989) 74 (4):291–301.
   PubMed Web of Science ®Google Scholar
• Thomas, E. J., and I. D. Cooke. 1987. Successful treatment of asymptomatic endometriosis: Does it benefit infertile women? BMJ 294 (6580):1117–9. doi: 10.1136/bmj.294.6580.1117.
   PubMedGoogle Scholar
• Ueki, M. 1991. Histologic study of endometriosis and examination of lymphatic drainage in and from the uterus. American Journal of Obstetrics and Gynecology 165 (1):201–9.
   PubMed Web of Science ®Google Scholar
• Uesato, S., Y. Kitagawa, M. Kamishimoto, A. Kumagai, H. Hori, and H. Nagasawa. 2001. Inhibition of green tea catechins against the growth of cancerous human colon and hepatic epithelial cells. Cancer Letters 170 (1):41–4.
   PubMed Web of Science ®Google Scholar
• Valle, R. F., and J. J. Sciarra. 2003. Endometriosis: Treatment strategies. Annals of the New York Academy of Sciences 997:229–39.
   PubMed Web of Science ®Google Scholar
• Vercellini, P., L. Fedele, G. Pietropaolo, G. Frontino, E. Somigliana, and P. G. Crosignani. 2003. Progestogens for endometriosis: Forward to the past. Human Reproduction Update 9 (4):387–96.
   PubMed Web of Science ®Google Scholar
• Vercellini, P., P. Vigano, E. Somigliana, and L. Fedele. 2014. Endometriosis: Pathogenesis and treatment. Nature Reviews. Endocrinology 10 (5):261–75.
   PubMed Web of Science ®Google Scholar
• Wang, J., G. C. W. Man, T. H. Chan, J. Kwong, and C. C. Wang. 2018. A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer. Cancer Letters 412:10–20. doi: 10.1016/j.canlet.2017.09.054.
   PubMed Web of Science ®Google Scholar
• Wang, D., E. W. Taylor, Y. Wang, X. Wan, and J. Zhang. 2012. Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention. International Journal of Nanomedicine 7:1711–21.
   PubMed Web of Science ®Google Scholar
• Wang, C. C., H. Xu, G. C. Man, T. Zhang, K. O. Chu, C. Y. Chu, J. T. Cheng, G. Li, Y. X. He, L. Qin, et al. 2013. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Angiogenesis 16 (1):59–69. doi: 10.1007/s10456-012-9299-4.
   PubMed Web of Science ®Google Scholar
• Xiao, J., C. T. Ho, E. C. Liong, A. A. Nanji, T. M. Leung, T. Y. Lau, M. L. Fung, and G. L. Tipoe. 2014. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. European Journal of Nutrition 53 (1):187–99. doi: 10.1007/s00394-013-0516-8.
   PubMed Web of Science ®Google Scholar
• Xu, H., C. M. Becker, W. T. Lui, C. Y. Chu, T. N. Davis, A. L. Kung, A. E. Birsner, R. J. D’amato, G. C. Wai Man, and C. C. Wang. 2011. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertility and Sterility 96 (4):1021–8. doi: 10.1016/j.fertnstert.2011.07.008.
   PubMed Web of Science ®Google Scholar
• Xu, Y., C. T. Ho, S. G. Amin, C. Han, and F. L. Chung. 1992. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Research 52:3875–9.
   PubMed Web of Science ®Google Scholar
• Xu, H., W. T. Lui, C. Y. Chu, P. S. Ng, C. C. Wang, and M. S. Rogers. 2008. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Human Reproduction 24 (3):608–18. doi: 10.1093/humrep/den417.
   PubMed Web of Science ®Google Scholar
• Yahfoufi, N., N. Alsadi, M. Jambi, and C. Matar. 2018. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients 10 (11):1618. doi: 10.3390/nu10111618.
   PubMed Web of Science ®Google Scholar
• Yang, C. S., and H. Wang. 2016. Cancer preventive activities of tea catechins. Molecules 21 (12):1679. doi: 10.3390/molecules21121679.
   PubMed Web of Science ®Google Scholar
• Yao, L., S. E. Pike, J. Setsuda, J. Parekh, G. Gupta, M. Raffeld, E. S. Jaffe, and G. Tosato. 2000. Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12. Blood 96 (5):1900–5.
   PubMed Web of Science ®Google Scholar
• Zhang, T., C. De Carolis, G. C. W. Man, and C. C. Wang. 2018a. The link between immunity, autoimmunity and endometriosis: A literature update. Autoimmunity Reviews 17 (10):945–55.
   PubMed Web of Science ®Google Scholar
• Zhang, T., J. Zhou, G. C. W. Man, K. T. Leung, B. Liang, B. Xiao, X. Ma, S. Huang, H. Huang, V. L. Hegde, et al. 2018b. MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target. European Journal of Immunology 48 (6):1059–73.
   PubMed Web of Science ®Google Scholar
• Zijp, I. M., O. Korver, and L. B. Tijburg. 2000. Effect of tea and other dietary factors on iron absorption. Critical Reviews in Food Science and Nutrition 40 (5):371–98.
   PubMed Web of Science ®Google Scholar